Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2022.11.17.516919

All-or-None Evaluation of Prediction Certainty in Autism

Reisli, S.·Crosse, M. J.·Molholm, S.
View original source ↗Export metadata ↓

Abstract

The brain generates predictions to prepare for upcoming events. As life is not always 100% predictable, it also estimates a level of certainty for these predictions. Given that autistic individuals resist even small changes in everyday life, we hypothesized impaired tuning of prediction certainty in autism. To study this, EEG was recorded from adolescents and young adults with autism while they performed a probabilistic prediction task in which cue validity was parametrically manipulated. A fully predictable condition (100% cue validity) was contrasted with less predictable conditions (84, 67 and 33% cue validity). Well characterized brain potentials were examined to assess the influence of cue validity on target anticipation (contingent negative variation; CNV), the evaluation of target statistics (P3), and prediction model updating (slow wave; SW). As expected, cue validity systematically influenced the amplitudes of the CNV, P3 and SW in controls. In contrast, cue-validity effects on CNV and SW were substantially reduced in autism. This suggests that although target statistics are accurately registered in autism, as indicated by intact modulation of the P3, they are not effectively applied to generate expectations for upcoming input or model updating. Contrasting the fully predictable with the less predictable conditions, our data suggest that autistic individuals adopted an all-or-none evaluation of certainty of their environment, rather than adjusting certainty of predictions to different levels of environmental statistics. Social responsiveness scores were associated with flexibility in representing prediction certainty, suggesting that impaired representation and updating of prediction certainty may contribute to social difficulties in autism. SIGNIFICANCE STATEMENTThe ability to make predictions is integral to everyday life. Yet, as life is not always 100% predictable and it is also essential to adjust the certainty of these predictions based on the current context. This study reveals that individuals with autism are less efficient in adjusting the certainty of their predictions to the level of predictability of events. Instead, they may adopt an all-or-none evaluation of certainty. Our findings reveal novel insights into the processes underlying impaired predictive processing in autism, which may open the door to developing targeted behavioral interventions and/or non-invasive brain stimulation therapies that help autistic individuals make more accurate predictions to ease social- and rigidity-based symptoms.

Explore related subjects

neurosciencePreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Reisli, S., Crosse, M. J., Molholm, S.. 2022-11-17. All-or-None Evaluation of Prediction Certainty in Autism. https://doi.org/10.1101/2022.11.17.516919

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗
bioRxiv2026

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗
bioRxiv2026

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗